GSK-3beta reduces cAMP-induced cholecystokinin gene expression by inhibiting CREB binding.

Source:http://linkedlifedata.com/resource/pubmed/id/15073527

Neuroreport 2004 Apr 9 15 5 841-5

Download in:

View as

General Info

PMID
15073527